Notice of Completion of US FDA Master File Registration for Ceglu™
NQ Score
78/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Sekisui Chemical has completed the US FDA Drug Master File (DMF) registration for Ceglu™, a chemically synthesized scaffold material for culturing iPS cells. This facilitates clinical trial and approval applications for pharmaceutical companies.